[Picotamide monohydrate prophylaxis of deep venous thrombosis in patients undergoing general surgery. Clinical experience].
The authors report their experience with the use of picotamide monohydrate for the prophylaxis of lower limb deep vein thrombosis in patients submitted to general surgery. Thirty-two patients were treated with the drug starting with 1200 mg daily three days before surgery and tapering to 900 mg daily in the postoperative period. The efficacy of the drug was found to be comparable to that of other currently used treatments and was not beset by a significant incidence of side effects.
Giberto
M
M
I Divisione di Chirurgia Generale, Ospedali Civili di Genova, Sampierdarena.
Canova
G
G
Masini
R
R
Damerio
M A
MA
Filippi
M
M
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010795:Phthalic Acids / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors; D013924:Thrombophlebitis / Q000517:prevention & control*
D010795:Phthalic Acids; C011581:picotamide
Profilassi con picotamide monoidrata della trombosi venosa profonda in pazienti sottoposti ad interventi di chirurgia generale. Esperienza clinica.